Description  Claims  Drawing  Cited references 

US5585089A   [0023] 
US5399346A   [0042] 
US6261569B   [0056] 
EP97994B   [0056] 
US20050287066A   [0067] 
US5219740A   [0076] 
US6048551A   [0077] 
US6306652B   [0077]  [0077] 
US5139941A   [0078]  [0078] 
US5622856A   [0078] 
US6001650A   [0078] 
US6004797A   [0078] 
WO9112882A   [0079] 
WO8903429A   [0079] 
WO9203545A   [0079] 
WO9507995A   [0080] 
WO9617072A   [0080] 
US5460950A   [0081] 
US5270181A   [0081] 
WO9014837A   [0084] 
USRE36397E   [0101] 
US3773919A   [0125] 
US3270960A   [0125] 
US3845770A   [0134] 
US3916899A   [0134] 
US3536809A   [0134] 
US3598123A   [0134] 
US4008719A   [0134] 
US5674533A   [0134] 
US5059595A   [0134] 
US5591767A   [0134] 
US5120548A   [0134] 
US5073543A   [0134] 
US5639476A   [0134] 
US5354556A   [0134] 
US5733566A   [0134] 
US6365185B1   [0134] 
US4747825A   [0136] 
US4723958A   [0136] 
US4948592A   [0136] 
US4965251A   [0136] 
US5403590A   [0136] 
WO62052111A   [0186] 

Remington: The Science and Practice of Pharmacy   [0023] 
Introduction to Nanoscience and Nanotechnology   [0023] 
Dictionary of Microbiology and Molecular Biology   [0023] 
March's Advanced Organic Chemistry Reactions, Mechanisms and Structure   [0023] 
Dictionary of DNA and Genome Technology   [0023] 
Molecular Cloning: A Laboratory Manual   [0023] 
Antibodies A Laboratory Manual   [0023] 
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion   [0023] 
Reshaping human antibodies for therapy   [0023] 
The 5-Minute Pediatric Consult   [0024] 
The Harriet Lane Handbook: A Manual for Pediatric House Officers   [0024] 
Current Diagnosis and Treatment in Pediatrics (Current Pediatrics Diagnosis & Treatment)   [0024] 
Int J Pept Protein Res.   [0056] 
J. Chem. Soc. Perkin Trans.   [0056] 
Biochemistry   [0060] 
Drug Latentiation   [0069] 
Application of Physical Organic Principles to Prodrug Design   [0069] 
Bioreversible Carriers in Drug in Drug Design, Theory and Application   [0069] 
Design of Prodrugs   [0069] 
Prodrug approaches to the improved delivery of peptide drug   [0069] 
Improvement in peptide bioavailability: Peptidomimetics and Prodrug Strategies   [0069] 
The Use of Esters as Prodrugs for Oral Delivery of (3-Lactam antibiotics   [0069] 
Designing Prodrugs and Bioprecursors I. Carrier Prodrugs   [0069] 
Improving Oral Drug Transport   [0069] 
Prodrugs for the improvement of drug absorption via different routes of administration   [0069] 
Involvement of multiple transporters in the oral absorption of nucleoside analogues   [0069] 
Fosphenytoin (Cerebyx)   [0069] 
Bioreversible derivatization of drugs-principle and applicability to improve the therapeutic effects of drugs   [0069] 
Improved drug delivery by the prodrug approach   [0069] 
Prodrugs as a means to improve the delivery of peptide drugs   [0069] 
Improved oral drug delivery: solubility limitations overcome by the use of prodrugs   [0069] 
Design of prodrugs for improved gastrointestinal absorption by intestinal enzyme targeting   [0069] 
Biologically Reversible Phosphate-Protective Groups   [0069] 
Bioreversible Protection for the Phospho Group: Chemical Stability and Bioactivation of Di(4-acetoxy-benzyl) Methylphosphonate with Carboxyesterase   [0069] 
Prodrugs of phosphates and phosphonates: Novel lipophilic alphaacyloxyalkyl ester derivatives of phosphate- or phosphonate containing drugs masking the negative charges of these groups   [0069] 
Pro-drug, molecular structure and percutaneous delivery   [0069] 
Penicillins: a current review of their clinical pharmacology and therapeutic use   [0069] 
Prodrugs of anticancer agents   [0069] 
Prodrugs. Do they have advantages in clinical practice?   [0069] 
Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics   [0069] 
Improved passive oral drug delivery via prodrugs   [0069] 
Prodrug strategies to enhance the intestinal absorption of peptides   [0069] 
Concepts for the design of anti-HIV nucleoside prodrugs for treating cephalic HIV infection   [0069] 
Prodrugs   [0069] 
Retroviruses: Molecular Biology, Genomics and Pathogenesis   [0076] 
Pharmacological Reviews   [0076] 
J. Virol.   [0077] 
J. Virol.   [0077] 
Human Gene Therapy   [0077] 
J. Virol.   [0077] 
Gene Therapy   [0077] 
BioTechniques   [0077] 
Human Gene Therapy   [0077] 
Anesthes.   [0077] 
Clin. Genet.   [0077] 
Curr. Opin. Mol. Ther.   [0077] 
J. Biol. Chem.   [0080] 
Proc. Natl. Acad. Sci. USA   [0080] 
J. Virol.   [0080] 
J Cell Biol   [0081] 
Curr Biol.   [0081] 
Biochem. J.   [0081] 
Gene Transfer into Mouse Lyoma Cells by Electroporation in High Electric Fields   [0083] 
Electric Field Mediated Gene Transfer   [0083] 
Enhancer-dependent Expression of Human Kappa Immunoglobulin Genes Introduced into Mouse pre-B Lymphocytes by Electroporation   [0083] 
Molecular Cloning: A Laboratory Manual   [0083] 
Liposome-mediated Delivery of Tobacco Mosaic Virus RNA into Tobacco Protoplasts: A Sensitive Assay for Monitoring Liposome-protoplast Interactions   [0083] 
Biotherapy   [0084] 
Vaccine Design   [0084] 
Nature Medicine   [0084] 
Adoptive transfer of virus-specific and tumor-specific T cell immunity   [0085] 
Polymersomes: A new multi-functional tool for cancer diagnosis and therapy   [0088] 
Gold nanoparticles as novel agents for cancer therapy   [0088] 
Principles of Cancer Management: Radiation Therapy   [0102] 
Pharmaceuticals   [0107] 
Molecular Cloning: A Laboratory Manual   [0109] 
Methods in Enzymology   [0109] 
Gene Expression Technology: Methods in Enzymology   [0109] 
Vectors used for expression in mammalian cells   [0111] 
BioTechnique   [0112] 
Proc. Natl. Acad. Sci. USA   [0112] 
Focus   [0112] 
Proc. West. Pharmacol. Soc.   [0112] 
Remington: The Science and Practice of Pharmacy   [0120] 
Ann. Rev. Pharmacol. Toxicol.   [0125] 
Controlled Release of Pesticides and Pharmaceuticals   [0125] 
J. Pharm. Res.   [0131] 
J. Int. J. Pharm.   [0131] 
Aerosols for delivery of therapeutic an diagnostic agents to the respiratory tract   [0131] 
Am. Rev. Respir. Dis.   [0131] 
Advanced Drug Delivery Reviews   [0131] 
Int. J. Pharm.   [0131] 
Spray Technol. Market   [0131] 
Aerosol Sci.   [0131] 
Powder Technology   [0131] 
J. Controlled Release   [0131] 
Biomed. Mater. Res.   [0131] 
Drug Delivery   [0131] 
Adv. Drug Del. Rev.   [0131] 
Adv. Drug. Del. Rev.   [0131] 
Controlled Release   [0131] 
Nature Biotechnology   [0131] 
Pharm. Res.   [0131] 
Pharm. Res.   [0131] 
Drug Stability: Principles & Practice   [0132] 
Controlled Release Dosage Form Design   [0133] 
Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses   [0148] 
Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis   [0150]  [0156] 
Carbon monoxide-based therapy ameliorates acute pancreatitis via TLR4 inhibition   [0150]  [0153]  [0156] 
Models of acute and chronic pancreatitis   [0150] 
Myeloid, but not pancreatic, RelA/p65 is required for fibrosis in a mouse model of chronic pancreatitis   [0150] 
Identification, culture, and characterization of pancreatic stellate cells in rats and humans   [0156]  [0156] 
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture   [0156] 
Isolation and differentiation of monocytes-macrophages from human blood   [0156] 
Gastroenterology   [0159] 
Gastroenterology   [0159] 
Gastroenterology   [0159]  [0173] 
Gastroenterology   [0159] 
J. Clin. Invest.   [0160] 
J. Exp. Med.   [0161] 
Gastroenterology   [0162] 
Nat. Immunol.   [0162] 
J. Leukoc. Biol   [0164] 
Immunity   [0164] 
J. Clin. Invest.   [0165]  [0178] 
Nat. Rev. Immunol.   [0165] 
J. Clin. Invest.   [0167]  [0175] 
Nature   [0169]  [0170] 
Immunity   [0170] 
J. Gastroenterol. Hepatol.   [0173] 
Semin. Liver Dis.   [0174] 
Nat. Rev. Immunol.   [0175] 
Exerc. Immunol. Rev.   [0175]  [0176] 
Gut   [0175] 
Am. J. Pathol.   [0175] 
J. Immunol.   [0176] 
J. Leukoc. Biol.   [0176] 
Clin. Exp. Immunol.   [0176] 
Nat. Rev. Immunol.   [0176] 
Annu. Rev. Immunol.   [0176] 
Cancer Res.   [0178] 
Cancer Res.   [0178]